In MDS, AML, MDS/AML, 27 (51%) of cases presented with an abnormal karyotype particularly encompassing the RUNX1 locus, 23 (43%) showed a somatic RUNX1 alteration, and 42 (79%) had additionally acquired variants (Figure 1). This evidence concerns the gene RUNX1 and acute myeloid leukemia.